MetalloPharm

Basic Information

1790 Riverstone Drive
Delaware, OH, 43015-7085

Company Profile

n/a

Additional Details

Field Value
DUNS: 140535845
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 4


  1. SBIR Phase I: A Diagnostic Device for Bacterial Detection

    Amount: $150,000.00

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop a simple general test strip that can be broadly used for the detection and chara ...

    SBIR Phase I 2014 National Science Foundation
  2. Novel Catalytic MetalloDrug Targeting IRES RNA for Treatment of HCV Infection

    Amount: $2,004,496.00

    DESCRIPTION (provided by applicant): HCV is responsible for 60% of the cases of chronic hepatitis and 50% of cases of cirrhosis, end- stage liver disease, and liver cancer. An effective vaccine has pr ...

    SBIR Phase II 2011 Department of Health and Human Services
  3. Metallodrugs Targeting HCV Protease

    Amount: $444,050.00

    DESCRIPTION (provided by applicant): Alcohol is a high risk factor in hepatitis C virus (HCV) infection and increases the severity of the infection. It has been estimated that 35% of alcohol-dependent ...

    SBIR Phase I 2009 Department of Health and Human Services
  4. Novel Engineered Synthetic Metallodrugs Directed Against HCV

    Amount: $256,722.00

    DESCRIPTION (provided by applicant): Alcohol is a high risk factor in hepatitis C virus (HCV) infection and increases the severity of the infection. It has been estimated that 35% of alcohol-dependent ...

    SBIR Phase I 2007 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government